Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 84

Sort by

Sort Order Select

Journal Articles

Immune dysregulation in patients with RAG deficiency and other forms of combined immune deficiency

Ottavia M. Delmonte, Anna Villa, Luigi D. Notarangelo

Blood (2020) 135 (9): 610–619.

https://doi.org/10.1182/blood.2019000923

Published: 2020

Journal Articles

Cross-Sectional Comparative Study of PK-Guided Switch between Standard Half-Life and Extended Half-Life Factor VIII Products

Blood (2019) 134 (Supplement_1): 2405.

https://doi.org/10.1182/blood-2019-127946

Published: 2019

Journal Articles

Real-World Clinical Management of Patients with Hemophilia and Inhibitors: Effectiveness and Safety of aPCC in Patients with >18 Months' Follow-up in the FEIBA Global Outcome Study (FEIBA GO)

Jerzy Windyga, Pal A Holme, C. Hermans, Ana R Cid, Nirjhar Chatterjee, Hongyu Jiang, Viridiana Cano-Garcia, Carmen Escuriola

Blood (2019) 134 (Supplement_1): 2418.

https://doi.org/10.1182/blood-2019-124324

Published: 2019

Journal Articles

Inducible MyD88 Signaling Enhances the Anti-AML Activity of BiTE-Secreting ENG T-Cells

Abishek Vaidya, MS, Erin E Doherty, MD, Xiya Wu, Challice L. Bonifant, MD PhD, Stephen Gottschalk, MD, Mireya Paulina Velasquez, MD

Blood (2019) 134 (Supplement_1): 4441.

https://doi.org/10.1182/blood-2019-125395

Published: 2019

Journal Articles

Benefits of Ehl Factor VIII Replacement Therapy in Hemophilia: Observations on Coverage, Physical Activity and Phisiotherapy

Felipe Querol, MD PhD, Sofía Pérez-Alenda, PhD, Juan Eduardo Megias, Juan José Carrasco, MSc, Marta Aguilar, PhD, Saturnino Haya, MD, Ana R Cid, Santiago Bonanad Boix, MD

Blood (2019) 134 (Supplement_1): 2455.

https://doi.org/10.1182/blood-2019-125651

Published: 2019

Journal Articles

Myd88/CD40 Costimulation to Enhance the Antitumor Activity of CD123-ENG T-Cells for the Immunotherapy of AML

Erin Doherty, MD, Abishek Vaidya, MS, Xiya Wu, Challice L. Bonifant, MD PhD, Melinda Mata, PhD, Ann M. Leen, PhD, Stephen Gottschalk, MD, Mireya P. Velasquez, MD

Blood (2018) 132 (Supplement 1): 4075.

https://doi.org/10.1182/blood-2018-99-116817

Published: 2018

Journal Articles

Spare the Spleen in ALPS: It Is Not an Expendable Vestigial Organ

V. Koneti Rao, MD FRCPA, Elaine Kulm, Susan Price, Sharon Webster, BSN, Les Folio, MD, Gulbu Uzel, MD, David T Teachey, MD

Blood (2018) 132 (Supplement 1): 2435.

https://doi.org/10.1182/blood-2018-99-117394

Published: 2018

Journal Articles

Impact of Intestinal Microbiota on Reconstitution of Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Stem Cell Transplantation

Alyssa Sheih, PhD, Jonathan L. Golob, MD, PhD, Abir Bhattacharyya, MBBS, Michael C. Wu, PhD, Aesha Vakil, MSc, Sujatha Srinivasan, PhD, Steven A. Pergam, MD MPH, David N. Fredricks, MD, Cameron J. Turtle, MBBS, PhD

Blood (2018) 132 (Supplement 1): 3393.

https://doi.org/10.1182/blood-2018-99-115158

Published: 2018

Journal Articles

Intestinal Enterococcus Is a Major Risk Factor for the Development of Acute Gvhd

Christoph K. Stein-Thoeringer, MD, Jonathan U. Peled, MD PhD, Antonio LC Gomes, PhD, Amina Lazrak, BS, Melissa D Docampo, BS, Ann E. Slingerland, BSc, Katherine Nichols, BS, Yusuke Shono, MD PhD, Daniela Weber, MD, Anthony D. Sung, MD, Daigo Hashimoto, MD, PhD, Justin Cross, PhD, Takanori Teshima, Ernst Holler, MD, Nelson J. Chao, MD, Eric G. Pamer, MD, Marcel R.M. van den Brink, MD PhD

Blood (2018) 132 (Supplement 1): 358.

https://doi.org/10.1182/blood-2018-99-119887

Published: 2018

Journal Articles

Gemtuzumab Ozogamicin in NPM1 -Mutated Acute Myeloid Leukemia (AML): Results from the Prospective Randomized AMLSG 09-09 Phase-III Study

Blood (2018) 132 (Supplement 1): 81.

https://doi.org/10.1182/blood-2018-99-113442

Published: 2018

Journal Articles

Gut Colonization with Carbapenem Resistant Enterobacteriaceae(CRE) Leads to More Chemotherapy Inerruptions and Higher Mortality in Patients with Acute Leukemias Receiving Remission Induction Chemotherapy

Sweta Kothari, MBBS. DNB, Rishi Dhawan, MD DM, Mukul Aggarwal, DM, Tulika Seth, MD MBBS, FAAP, Sarita Rath, MD, Manoranjan Mahapatra, MD

Blood (2018) 132 (Supplement 1): 4002.

https://doi.org/10.1182/blood-2018-99-120366

Published: 2018

Journal Articles

T-cell defects in patients with ARPC1B germline mutations account for combined immunodeficiency

Blood (2018) 132 (22): 2362–2374.

https://doi.org/10.1182/blood-2018-07-863431

Published: 2018

Includes: Supplemental data

Journal Articles

Hypomorphic Rag1 mutations alter the preimmune repertoire at early stages of lymphoid development

L. M. Ott de Bruin, M. Bosticardo, A. Barbieri, S. G. Lin, J. H. Rowe, P. L. Poliani, K. Ching, D. Eriksson, N. Landegren, O. Kämpe, J. P. Manis, L. D. Notarangelo

Blood (2018) 132 (3): 281–292.

https://doi.org/10.1182/blood-2017-12-820985

Published: 2018

Includes: Supplemental data

Journal Articles

Replenishment of Damaged Bone Marrow Niches By Circulating Hematopoietic Stem Cells

Itziar Cossío, Marianna Di Scala, Jose María Adrover, María Casanova-Acebes, Linnea Weiss, Christian Weber, Daniel Lucas-Alcaraz, PhD, Andres Hidalgo

Blood (2017) 130 (Supplement 1): 3750.

https://doi.org/10.1182/blood.V130.Suppl_1.3750.3750

Published: 2017

Journal Articles

"FEIBA Global Outcome Study (FEIBA GO)" Data Read-out: Real World Bleeding Frequency in Inhibitors Patients on Prophylaxis with APCC

C. Escuriola Ettingshausen, J. Windyga, MD, C. Hermans, MDMRCP,PhD, A.R. Cid, S. Rangarajan, A. Rocino, A. Gringeri, MD PhD, R. Crea, DVM, MSc

Blood (2017) 130 (Supplement 1): 4880.

https://doi.org/10.1182/blood.V130.Suppl_1.4880.4880

Published: 2017

Journal Articles

Novel nonsense gain-of-function NFKB2 mutations associated with a combined immunodeficiency phenotype

Hye Sun Kuehn, Julie E. Niemela, Karthik Sreedhara, Jennifer L. Stoddard, Jennifer Grossman, Christian A. Wysocki, M. Teresa de la Morena, Mary Garofalo, Jingga Inlora, Michael P. Snyder, David B. Lewis, Constantine A. Stratakis, Thomas A. Fleisher, Sergio D. Rosenzweig

Blood (2017) 130 (13): 1553–1564.

https://doi.org/10.1182/blood-2017-05-782177

Published: 2017

Includes: Supplemental data

Journal Articles

Successful Outcome Following Allogeneic Haematopoietic Stem Cell Transplantation in Adults with Inherited Primary Immunodeficiency (PID)

Emma C Morris, MD PhD, Thomas Andrew Fox, MRCP, Siobhan Burns, MD PhD, Ben Carpenter, MD, Kirsty J Thomson, MD, David Lowe, MD PhD, Adele K. Fielding, MB BS, PhD FRCP, FRCPath, Karl S Peggs, MD, Panagiotis Kottaridis, FRCPath, PhD MSc, Victoria Grandage, FRCPath, MRCP, PhD, Shari Denovan, RN, Sarah Grace, RN, Julia Dahlstrom, RN, Sarita Workman, RN, Andrew Symes, RN, Stephen Mackinnon, MD, Ronjon Chakraverty, BMBS, PhD, Rachael Hough, MD BMBS, FRCP, FRCPath

Blood (2016) 128 (22): 4681.

https://doi.org/10.1182/blood.V128.22.4681.4681

Published: 2016

Journal Articles

Improved Outcome and Decreased Morbidity and Mortality Rates of B-Cell Malignancies with Less Intensive Chemotherapy Induction: Experience in a Single Institution

Cristian G Sanchez La Rosa, MD, Myriam Guitter, MD, Alfaro Elizabeth, Natalia Millan, MD, Jorge Gabriel Rossi, PhD, Andrea Bernasconi, MS, Laura Galuzzo, Andrea Montanari, MD, Edgardo Baialardo, Pedro Zubizarreta, MD, Guillermo Chantada, Maria Sara Felice, MD PhD

Blood (2016) 128 (22): 1858.

https://doi.org/10.1182/blood.V128.22.1858.1858

Published: 2016

Journal Articles

Feiba Global Outcome Study (FEIBA-GO): Long-Term Real World Data on Apcc (Feiba R ) in Patients with Inhibitors. First Demographic Data

Ana Rosa Cid, MD, Carmen Escuriola, MD, Cedric R. Hermans, MD PhD MRCP, Pal André Holme, PhD MD, Claude Negrier, MD, Savita Rangarajan, Angiola Rocino, Jerzy Windyga, MD, Alessandro Gringeri, MD MSc, Roberto Crea, DVM, MSc

Blood (2016) 128 (22): 5038.

https://doi.org/10.1182/blood.V128.22.5038.5038

Published: 2016

Journal Articles

Mast Cell Regulatory Gene Variants Are Common in Mast Cell Activation Syndrome

Lawrence B Afrin, MD, Frank Cichocki, PhD, Andrea Hoeschen, M.A., Kenneth B Beckman, PhD, Kalpna Gupta, PhD, Julia Nguyen, BS, Kevin A Silverstein, PhD, Lauren J Mills, PhD

Blood (2016) 128 (22): 4878.

https://doi.org/10.1182/blood.V128.22.4878.4878

Published: 2016

NARROW

Immune dysregulation in patients with RAG deficiency and other forms of combined immune deficiency

Cross-Sectional Comparative Study of PK-Guided Switch between Standard Half-Life and Extended Half-Life Factor VIII Products

Real-World Clinical Management of Patients with Hemophilia and Inhibitors: Effectiveness and Safety of aPCC in Patients with >18 Months' Follow-up in the FEIBA Global Outcome Study (FEIBA GO)

Inducible MyD88 Signaling Enhances the Anti-AML Activity of BiTE-Secreting ENG T-Cells

Benefits of Ehl Factor VIII Replacement Therapy in Hemophilia: Observations on Coverage, Physical Activity and Phisiotherapy

Myd88/CD40 Costimulation to Enhance the Antitumor Activity of CD123-ENG T-Cells for the Immunotherapy of AML

Spare the Spleen in ALPS: It Is Not an Expendable Vestigial Organ

Impact of Intestinal Microbiota on Reconstitution of Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Stem Cell Transplantation

Intestinal Enterococcus Is a Major Risk Factor for the Development of Acute Gvhd

Gemtuzumab Ozogamicin in NPM1 -Mutated Acute Myeloid Leukemia (AML): Results from the Prospective Randomized AMLSG 09-09 Phase-III Study

Gut Colonization with Carbapenem Resistant Enterobacteriaceae(CRE) Leads to More Chemotherapy Inerruptions and Higher Mortality in Patients with Acute Leukemias Receiving Remission Induction Chemotherapy

T-cell defects in patients with ARPC1B germline mutations account for combined immunodeficiency

Hypomorphic Rag1 mutations alter the preimmune repertoire at early stages of lymphoid development

Replenishment of Damaged Bone Marrow Niches By Circulating Hematopoietic Stem Cells

"FEIBA Global Outcome Study (FEIBA GO)" Data Read-out: Real World Bleeding Frequency in Inhibitors Patients on Prophylaxis with APCC

Novel nonsense gain-of-function NFKB2 mutations associated with a combined immunodeficiency phenotype

Successful Outcome Following Allogeneic Haematopoietic Stem Cell Transplantation in Adults with Inherited Primary Immunodeficiency (PID)

Improved Outcome and Decreased Morbidity and Mortality Rates of B-Cell Malignancies with Less Intensive Chemotherapy Induction: Experience in a Single Institution

Feiba Global Outcome Study (FEIBA-GO): Long-Term Real World Data on Apcc (Feiba R ) in Patients with Inhibitors. First Demographic Data

Mast Cell Regulatory Gene Variants Are Common in Mast Cell Activation Syndrome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only